Results 171 to 180 of about 28,512 (352)

Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies. [PDF]

Biomedicines
Marino M, Rosset F, Nervo A, Piovesan A, Pala V, Vaccaro E, Mastorino L, Calogero AE, Arvat E.   +8 more
europepmc   +1 more source

Patient‐Reported Dysphagia and Swallowing‐Related Quality of Life up to 10 Years After (Chemo)radiotherapy for Head and Neck Cancer: A Cross‐Sectional Study

Head &Neck, EarlyView.
ABSTRACT Background This study sought to better understand patient‐reported dysphagia and swallowing‐related quality of life (swQOL) in patients 6 months to 10 years following definitive (chemo)radiotherapy for head and neck cancer (HNC). Methods In this cross‐sectional study, self‐reported dysphagia was assessed with the Eating Assessment Tool (EAT‐10)
Jacqui J. Frowen, Allison Drosdowsky, Tsien F. Fua, Lachlan J. McDowell, Karla Gough   +4 more
wiley   +1 more source

The Penetration of an Anticholinesterase Agent (Sarin) into Skin. III. A Method for Studying the Rate of Penetration into the Skin of the Living Rabbit11From the Dermatological Research Laboratories of the Department of Dermatology, Harvard Medical School, at the Massachusetts General Hospital, Boston 14, Massachusetts.

, 1958
Robert D. Griesemer, Irvin H. Blank, Edith Gould   +2 more
openalex   +1 more source

Study of the Etiological Agents of Dermatophytosis in Patients Attending Dermatology Clinics of a Suburban Tertiary Care-centre in Western Maharashtra, India [PDF]

, 2019
Kalpana Angadi, Rabindranath Misra, Nikunja Kumar Das, Shrea Kapoor, Shahzad Mirza   +4 more
openalex   +1 more source

Inclisiran-Induced Fixed Drug Eruption in a Patient With Refractory Hypercholesterolemia. [PDF]

Cureus
Khan JA, Shahab S.
europepmc   +1 more source

Loss of the Y Chromosome in Oral Potentially Premalignant Disorders Predicts Malignant Progression: An Integrative Cross‐Species Multi‐Cohort Bioinformatic Study

Head &Neck, EarlyView.
ABSTRACT Background The loss of the Y chromosome (LOY) and the extreme down‐regulation of Y chromosome gene expression (EDY) are frequently observed in oral squamous cell carcinoma (OSCC). However, their roles in oral potentially malignant disorders (OPMDs) are unclear.
Rui Han, Jos B. Poell, Cristina Conde‐Lopez, Tuula Salo, Ina Kurth, Ruud H. Brakenhoff, Jochen Hess   +6 more
wiley   +1 more source

POTASSIUM PERMANGANATE AS A CURATIVE AGENT IN DERMATOLOGIC DISEASES

, 1922
Samuel M. Feldman
openalex   +2 more sources

Floseal® use in dermatologic surgical management of vascular malformations: A novel haemostatic agent in Côte d’Ivoire

, 2021
K. Kassi, Bamba Vagamon, Kouamé Kanga, Aang Allou, Alexandre Kouassi, Ildevert Patrice Gbéry, Sarah Kourouma, Isidore Kouassi, E.J. Ecra, M Kaloga, Abdoulaye Sangaré, Pauline Yoboue-Yao, J.M. Kanga   +12 more
openalex   +2 more sources

Primary care physicians prescribe fewer expensive combination medications than dermatologists for acne: A retrospective review. [PDF]

J Manag Care Spec Pharm
Keime N, Titus O, Ziogaite M, Hugh J, Schilling LM, Dellavalle R, Billups SJ.   +6 more
europepmc   +1 more source

Neoadjuvant Immunotherapy for Periauricular Cutaneous Squamous Cell Carcinoma

Head &Neck, EarlyView.
ABSTRACT Background The standard‐of‐care for advanced periauricular cutaneous squamous cell carcinoma (pCSCC) is surgery and adjuvant radiation therapy. Neoadjuvant immunotherapy recently demonstrated high pathologic response rates in patients with resectable pCSCC.
David Z. Allen, Neil Gross, Marc‐Elie Nader, Renata Ferrarotto, Moran Amit, Priyadharsini Nagarajan, Paul Gidley   +6 more
wiley   +1 more source